In just one year, the healthcare supply chain leader achieves 80% YoY growth, ₹582 crore (including GMV) topline in Q2, and turns EBITDA positive through disciplined execution and strategic realignment.One year ago, Medikabazaar embarked on a strategic path of hypergrowth with a clear focus on profitability.
New Delhi, September 3rd, 2025: Poly Medicure Ltd. (NSE: POLYMED | BSE: 531768), India’s leading Medical Device company with a dominant position in medical consumables market, today announced signing of definitive agreements to acquire 90% stake in PendraCare Group consisting of PendraCare Holdings and Wellinq
